Pune: The mortality rate of Guillain-Barre Syndrome (GBS) has exceeded 4 per cent in Pune, with 8 fatalities recorded among 203 cases detected in the last month. This rate is significantly higher than the COVID-19 fatality rate in Pune, which stood at 1-1.5% during the pandemic.

Despite a relatively low case count, medical experts are concerned about the high mortality rate associated with the disease. The most recent GBS-related death occurred early Wednesday (February 12) morning, when a 59-year-old resident of Khadakwasla passed away at Shrimati Kashibai Navale Hospital in Narhe.

Doctors reported that the patient had been experiencing weakness since February 10 and was unable to stand up from a seated position. Healthcare professionals emphasize that early diagnosis and immediate treatment are critical in reducing fatalities associated with GBS.

Patients who develop severe complications and require ventilator support face an increased risk of mortality, said Dr. Bhushan Kinholkar, a critical care specialist.

"To control the death rate, it is crucial to diagnose GBS cases early and initiate prompt treatment. Patients requiring ventilator support are at a much higher risk of complications and death," he added.

Senior neurologist Dr. Sudhir Kothari explained that GBS is often triggered by the Campylobacter jejuni bacteria, which makes the disease more aggressive and deadly.

"Many patients report prior stomach infections, suggesting that they had Campylobacter jejuni exposure before developing GBS. However, it is important to note that GBS alone does not always cause death—other underlying conditions often contribute to fatal cases," Dr. Kothari said.